The petition seeks a waiver of its administrative rules of 64F-12.015 F.A.C. Petitioner asserts that Petition is a virtual pharmaceutical company that does not handle, store or distribute drugs from their establishment and thus is seeking a waiver ...  

  •  

    DEPARTMENT OF BUSINESS AND PROFESSIONAL REGULATION

    Drugs, Devices and Cosmetics

    NOTICE IS HEREBY GIVEN that on July 23, 2015, the Division of Drugs, Devices and Cosmetics has received the petition for Variance and Waiver from Piushbhai Patel, on behalf of Accelis Pharma. The petition seeks a waiver of its administrative rules of Rule 64F-12.015 F.A.C. Petitioner asserts that Petition is a virtual pharmaceutical company that does not handle, store or distribute drugs from their establishment and thus is seeking a waiver of the statutory requirement for wholesale distributors and out-of-state wholesale distributors to employ a certified designated representative in accordance with the provision of Section 499.012(16), F.S.

    A copy of the Petition for Variance or Waiver may be obtained by contacting: The Division of Drugs, Devices and Cosmetics, 1940 N. Monroe Street, Suite 26A, Tallahassee, FL 32399-1047.

    Please refer all comments to: Reggie Dixon, Executive Director, Division of Drugs, Devices and Cosmetics, 1940 N. Monroe Street, Suite 26A, Tallahassee, FL 32399-1047, web-site: http://interredesignalpha/dbpr/ddc/ddc_division_notices.html.

Document Information

Contact:
The Division of Drugs, Devices and Cosmetics, 1940 N. Monroe Street, Suite 26A, Tallahassee, FL 32399-1047 Please refer all comments to: Reggie Dixon, Executive Director, Division of Drugs, Devices and Cosmetics, 1940 N. Monroe Street, Suite 26A, Tallahassee, FL 32399-1047 web-site: http://interredesignalpha/dbpr/ddc/ddc_division_notices.html.